Pubblicazioni

Phosphodiesterase inhibitors: Could they be beneficial for the treatment of COVID-19?

2020 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Giorgi, M.; Cardarelli, S.; Ragusa, F.; Saliola, M.; Biagioni, S.; Poiana, G.; Naro, F.; Massimi, M.

EAPCI position statement on invasive management of acute coronary syndromes during the COVID-19 pandemic

2020 - EUROPEAN HEART JOURNAL

Chieffo, A.; Stefanini, G. G.; Price, S.; Barbato, E.; Tarantini, G.; Karam, N.; Moreno, R.; Buchanan, G. L.; Gilard, M.; Halvorsen, S.; Huber, K.; James, S.; Neumann, F. -J.; Mollmann, H.; Roffi, M.; Tavazzi, G.; Ferre, J. M.; Windecker, S.; Dudek, D.; Baumbach, A.

The rationale for angiotensin receptor neprilysin inhibitors in a multi-targeted therapeutic approach to COVID-19

2020 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Bellis, A.; Mauro, C.; Barbato, E.; Trimarco, B.; Morisco, C.

Homocysteine as a potential predictor of cardiovascular risk in patients with COVID-19

2020 - MEDICAL HYPOTHESES

Ponti, G.; Ruini, C.; Tomasi, A.

Complement C3 vs C5 inhibition in severe COVID-19. Early clinical findings reveal differential biological efficacy

2020 - CLINICAL IMMUNOLOGY

Mastellos, Dimitrios C; Pires da Silva, Bruno G P; Fonseca, Benedito A L; Fonseca, Natasha P; Auxiliadora-Martins, Maria; Mastaglio, Sara; Ruggeri, Annalisa; Sironi, Marina; Radermacher, Peter; Chrysanthopoulou, Akrivi; Skendros, Panagiotis; Ritis, Konstantinos; Manfra, Ilenia; Iacobelli, Simona; Huber-Lang, Markus; Nilsson, Bo; Yancopoulou, Despina; Connolly, E Sander; Garlanda, Cecilia; Ciceri, Fabio; Risitano, Antonio M; Calado, Rodrigo T; Lambris, John D